Therapeutic Options for NSCLC with Rare Mutations

Opinion
Video

The Oncology Brothers and Balazs Halmos, MD, provide clinical insights on therapeutic options for patients with NSCLC with rare mutations, including ROS1, BRAF V600E, and NTRK.

Recent Videos
6 experts are featured in this series.
6 experts are featured in this series.
3 experts in this video
3 experts in this video
3 experts in this video
6 experts are featured in this series.
6 experts are featured in this series.
Related Content